Leukemia, Promyelocytic, Acute
"Leukemia, Promyelocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Descriptor ID |
D015473
|
| MeSH Number(s) |
C04.557.337.539.275.700
|
| Concept/Terms |
Leukemia, Promyelocytic, Acute- Leukemia, Promyelocytic, Acute
- Leukemia, Acute Promyelocytic
- Leukemia, Myeloid, Acute, M3
- M3 ANLL
- ANLL, M3
- Myeloid Leukemia, Acute, M3
- Progranulocytic Leukemia
- Promyelocytic Leukemia, Acute
- AML M3
- Acute Promyelocytic Leukemia
- Acute Promyelocytic Leukemias
- Leukemia, Progranulocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Promyelocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Promyelocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Promyelocytic, Acute" by people in this website by year, and whether "Leukemia, Promyelocytic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Promyelocytic, Acute" by people in Profiles.
-
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia. Cancer. 2025 Jan 01; 131(1):e35662.
-
Outcome of Patients With Relapsed Acute Promyelocytic Leukemia. Clin Lymphoma Myeloma Leuk. 2024 Jun; 24(6):375-381.
-
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leuk Lymphoma. 2024 Mar; 65(3):378-382.
-
A global study for acute myeloid leukemia with RARG rearrangement. Blood Adv. 2023 07 11; 7(13):2972-2982.
-
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2023 01; 23(1):1-7.
-
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry. Cytometry B Clin Cytom. 2022 07; 102(4):283-291.
-
Tumor suppressor function of WT1 in acute promyelocytic leukemia. Haematologica. 2022 01 01; 107(1):342-346.
-
[Acute promyelocytic leukemia complicated with central nervous system involvement successfully treated with all-trans retinoic acid via nasogastric tube]. Rinsho Ketsueki. 2022; 63(1):26-30.
-
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leuk Lymphoma. 2022 03; 63(3):672-675.
-
Acute promyelocytic leukemia current treatment algorithms. Blood Cancer J. 2021 06 30; 11(6):123.